Lv6
2403 积分 2022-07-20 加入
Determinants of willingness to pay for health services: a systematic review of contingent valuation studies
2小时前
待确认
Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
8天前
已完结
Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group
8天前
已完结
Multiple myeloma
8天前
已完结
MM-613 Healthcare Resource Utilization and Costs Among Patients With Relapsed/Refractory Multiple Myeloma Treated With Chimeric Antigen Receptor-T (CAR-T) Cell Therapy
9天前
已关闭
Willingness to pay to enhance pandemic preparedness in Mauritius
13天前
已完结
Inhibiting BTK in Chronic Lymphocytic Leukemia
16天前
已完结
Ibrutinib in combination with rituximab in relapsed or refractory mantle cell lymphoma: a single-centre, open-label, phase 2 trial
16天前
已完结
LOXO-305, A Next Generation Reversible BTK Inhibitor, for Overcoming Acquired Resistance to Irreversible BTK Inhibitors
16天前
已完结
皖公网安备34019202002308
